Search

everythinglearnresearchcommunity

for

Search:↓

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

New compounds can block testosterone effects in rats and might help treat conditions like prostate cancer and acne.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Liquorice may reduce testosterone and affect male reproductive organs, potentially helping treat conditions like prostate cancer.

Finasteride may help prevent chronic bacterial prostatitis, with better results when combined with antibiotics.

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

Created microspheres show potential for safe and effective use in prostate artery embolization.

A new method was developed to make finasteride for treating hair loss.

Finasteride effectively reduces symptoms of enlarged prostate with minimal side effects.

Dihydrotestosterone treatment can help penis growth in boys with 5α-reductase deficiency but doesn't fully normalize size after puberty.

5ARIs like finasteride can help prevent prostate cancer and treat BPH, but guidelines should be updated to reflect this.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Dutasteride reduces DHT more effectively than finasteride.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Combination therapy for BPH is cost-effective, especially for men with larger prostates.

Cyproterone acetate can cause rare shortness of breath in women.

Finasteride, a hair loss drug, may cause sexual dysfunction and depression, but these effects are usually temporary and the drug is generally safe. More research is needed.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Finasteride can cause sexual dysfunction, sperm changes, and affect bone density and metabolism.

D-004 may be a natural alternative to finasteride for treating enlarged prostate and male baldness.

Dosing time affects finasteride's effectiveness and safety in rats.

Omega-6 fats in certain cells boost male hormone production.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

Finasteride reduces prostate size and symptoms with few side effects.

Balding and low testosterone increase risk of urinary stones.

Accurate protein modeling can help develop new treatments for prostate cancer and other diseases.

Alopecia should be treated as a medical condition because it may increase the risk of serious diseases and psychological issues.